Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing glycoprotein B of infectious laryngotracheitis virus and chicken IL-18.
Autor: | Chen HY; College of Animal Science and Veterinary Medicine, Henan Agricultural University, Zhengzhou, Henan Province, China., Cui P, Cui BA, Li HP, Jiao XQ, Zheng LL, Cheng G, Chao AJ |
---|---|
Jazyk: | angličtina |
Zdroj: | FEMS immunology and medical microbiology [FEMS Immunol Med Microbiol] 2011 Nov; Vol. 63 (2), pp. 289-95. |
DOI: | 10.1111/j.1574-695X.2011.00850.x |
Abstrakt: | Infectious laryngotracheitis virus (ILTV) is an alphaherpesvirus that causes severe and economically significant respiratory disease in poultry worldwide. Herein, the immunogenicity of two recombinant fowlpox viruses (rFPV-gB and rFPV-gB/IL18) containing ILTV glycoprotein B (gB) and chicken interleukin-18 (IL-18) were investigated in a challenge model. One-day-old specific-pathogen-free chickens were vaccinated by wing-web puncture with the two rFPVs and challenged with the virulent ILTV CG strain. There were differences in antibody levels elicited by either rFPV-gB/IL18 or rFPV-gB as determined using ELISA. The ratios of CD4(+) to CD8(+) in chickens immunized with rFPV-gB/IL18 were higher (P < 0.05) than in those immunized with rFPV-gB, and the level of proliferative response of the T cells in the rFPV-gB/IL18-vaccinated group was higher (P < 0.05) than that in the rFPV-gB group. All chickens immunized with rFPV-gB/IL18 were protected (10/10), whereas only eight of 10 of the chickens immunized with the rFPV-gB were protected. The results showed that the protective efficacy of the rFPV-gB vaccine could be enhanced by simultaneous expression of chicken IL-18. (© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |